LSNE Contract Manufacturing Revenue and Competitors

Bedford, NH USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • LSNE Contract Manufacturing's estimated annual revenue is currently $45.3M per year.(i)
  • LSNE Contract Manufacturing's estimated revenue per employee is $155,000

Employee Data

  • LSNE Contract Manufacturing has 292 Employees.(i)
  • LSNE Contract Manufacturing grew their employee count by -9% last year.

LSNE Contract Manufacturing's People

NameTitleEmail/Phone
1
VP OperationsReveal Email/Phone
2
Head ProductionReveal Email/Phone
3
Associate Director, Process DevelopmentReveal Email/Phone
4
Director Engineering and Capital ProjectsReveal Email/Phone
5
Associate QA Director, Quality Systems & ComplianceReveal Email/Phone
6
Director Quality Assurance, Site Quality HeadReveal Email/Phone
7
Director, Quality ControlReveal Email/Phone
8
IT DirectorReveal Email/Phone
9
Director - Manufacturing Science & TechnologyReveal Email/Phone
10
Associate Director, QC MicrobiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.5M681%N/AN/A
#2
$4.3M284%N/AN/A
#3
$2M138%N/AN/A
#4
$1.1M70%N/AN/A
#5
$3.7M24-11%N/AN/A
#6
$1.1M70%N/AN/A
#7
$45.3M292-9%N/AN/A
#8
$1.4M90%N/AN/A
#9
$2M138%N/AN/A
#10
$7M45-34%N/AN/A
Add Company

What Is LSNE Contract Manufacturing?

LSNE Contract Manufacturing is a CMO with a proven regulatory history specializing in a wide range of services including process development, fill/finish and lyophilization. LSNE has been providing cGMP services to the pharmaceutical, biotechnology and medical device industries since 1997. Through the thoughtful integration of three processing facilities, qualified staffing and an extensive manufacturing history, LSNE is strategically positioned to provide uninterrupted material for clinical through commercial use. With on-site development services, LSNE can partner with clients to optimize their current formulation and lyophilization cycle or develop a cycle from scratch and perform the necessary feasibility work. Once development activities are complete, LSNE can formulate, fill, lyophilize and package finished products. LSNE's highly skilled personnel and automated equipment, work together to provide consistent, quality material. LSNE offers both the flexible approach commonly required with preclinical projects, as well as the cGMP framework necessary for late stage clinical and commercial manufacturing. Specializing in the production of high-quality small to medium size batches, LSNE is perfectly suited for orphan indications or products with modest annual volumes. LSNE's experienced development, operations, quality and project management teams evaluate project objectives and recommend an optimal path forward to achieve easier regulatory submissions and a faster time to market. LSNE's flexibility and responsiveness allow them to make their client's batch a top priority so they can meet their client's timelines and exceed their expectations. For more information, contact LSNE Contract Manufacturing at (603) 668-5763 or visit www.lyophilization.com.

keywords:Biotechnology,Healthcare

N/A

Total Funding

292

Number of Employees

$45.3M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LSNE Contract Manufacturing News

2022-04-06 - Global Aseptic Pharma Processing Market, By Component, By Technology, By Product, By Application, By Region, Competition Forecast and Opportunities, 2017-2027

... Symbiosis Pharmaceutical Services Ltd., Catalent Pharma Solutions Inc., Alcami Corporation, LSNE Contract Manufacturing, IRISYS,...

2021-01-14 - LSNE Expands Vial Fill Finish and Lyophilization Operations with New Automated Fill Line

BEDFORD, N.H., Jan. 14, 2021 /PRNewswire/ -- LSNE Contract Manufacturing, a leading contract development and manufacturing organization (CDMO) expands vial filling and lyophilization capacity with the addition of a new automated aseptic fill line. The new aseptic fill line will be housed in an ...

2020-08-27 - LSNE-León Receives Approval From AEMPS To Manufacture Biotechnology Based Therapeutic Products

BEDFORD, N.H., Aug. 27, 2020 /PRNewswire/ -- LSNE Contract Manufacturing, a leading contract development and manufacturing organization, is pleased to announce that the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved the manufacturing of clinical stage biotechnology based ...

2019-06-19 - LSNE acquires sterile injectables manufacturing facility

Lyophilization Services of New England, a Bedford-based contract manufacturer, has acquired a sterile injectables manufacturing facility in ...

2019-06-17 - LSNE Completes Acquisition of Sterile Injectables ...

LSNE Completes Acquisition of Sterile Injectables Manufacturing Facility ... (LSNE), a leading contract development and manufacturing ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$54.9M303N/AN/A
#2
$120.9M31413%N/A
#3
$56.2M316-9%$12.2M
#4
$59.6M3290%N/A
#5
$60.2M332-11%N/A